High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$59.1M
$59,071,189
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-04-02 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-04-02 | $278,276 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-04-01 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-04-01 | $275,417 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-31 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-31 | $256,357 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-30 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-30 | $240,728 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-27 | $34,198 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-27 | $220,021 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-27 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-26 | $269,127 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-26 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-25 | $271,986 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-25 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-24 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-24 | $261,122 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-23 | $263,600 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-23 | $107,029 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-20 | $25,800 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-20 | $78,392 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-20 | $254,832 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-19 | $251,211 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-19 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-18 | $251,211 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-18 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-17 | $255,404 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-17 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-16 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-16 | $255,595 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-13 | $247,018 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-13 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-12 | $172,526 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-12 | $72,522 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-12 | $96,429 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS CHAD M
• CEO
Sell to CoverΔOwn -12.5%
2026-03-11
$4,340,832Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
Sell to CoverΔOwn -12.5%
|
2026-03-11 | $4,340,832Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BOBULSKY SUSAN
• Officer • Chief Commercial Officer, MRD
Sell to Cover
2026-03-11
$544,421
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Officer, MRD
Sell to Cover
|
2026-03-11 | $544,421 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Sell to CoverΔOwn -18.8%
2026-03-11
$831,067
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Sell to CoverΔOwn -18.8%
|
2026-03-11 | $831,067 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
Sell to CoverΔOwn -17.8%
2026-03-11
$4,340,832Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
Sell to CoverΔOwn -17.8%
|
2026-03-11 | $4,340,832Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
Sell to Cover
2026-03-11
$1,852,571Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-03-11 | $1,852,571Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-11 | $268,365 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-11 | $96,429 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
RUBINSTEIN JULIE
• COO
Sell to CoverΔOwn -19.0%
2026-03-11
$1,613,628Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Sell to CoverΔOwn -19.0%
|
2026-03-11 | $1,613,628Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Sell to Cover
|
2026-03-11 | $245,910 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
10b5-1 Sell
2026-03-11
$430,749
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
10b5-1 Sell
|
2026-03-11 | $430,749 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
Sell to Cover
|
2026-03-11 | $1,851,267Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
GRIFFIN MICHELLE RENEE
• Director
Discretionary SellΔOwn -49.6%
2026-03-11
$214,131
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Director
Discretionary SellΔOwn -49.6%
|
2026-03-11 | $214,131 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-10 | $4,856 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-10 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-10 | $285,673 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-09 | $457,617 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-09 | $144,235 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-09 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-06 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-06 | $144,235 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-06 | $468,447 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Sell to CoverΔOwn -10.6%
2026-03-05
$574,537
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Sell to CoverΔOwn -10.6%
|
2026-03-05 | $574,537 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-05 | $495,056 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-05 | $144,235 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-05 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-04 | $144,235 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-04 | $513,621 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-04 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-03 | $106,439 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $785,389 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $38,437 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-03
$235,129
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-03 | $235,129 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
Director
Other
|
2026-03-03 | $191,696 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
GRIFFIN MICHELLE RENEE
• Director
10b5-1 SellΔOwn -75.7%
2026-03-03
$735,073
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Director
10b5-1 SellΔOwn -75.7%
|
2026-03-03 | $735,073 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-03 | $96,429 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-03 | $144,235 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-03 | $378,312 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-02
$157,200
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-02 | $157,200 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS CHAD M
• CEO
10b5-1 SellΔOwn -12.7%
2026-03-02
$4,572,360Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 SellΔOwn -12.7%
|
2026-03-02 | $4,572,360Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-02-27 | $2,924,427Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 Sell
|
2026-02-04 | $39,597 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2026-02-04 | $26,040 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-03
$154,280
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-03 | $154,280 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-02
$644,825
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-02 | $644,825 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-02-02 | $2,304,963Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 Sell
|
2026-01-12 | $77,220 | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2026-01-12
$285,870
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2026-01-12 | $285,870 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2026-01-12
$93,757
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2026-01-12 | $93,757 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2026-01-12
$177,677
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2026-01-12 | $177,677 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2026-01-12
$56,718
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2026-01-12 | $56,718 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
10b5-1 SellΔOwn -20.1%
2026-01-12
$1,411,131Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
10b5-1 SellΔOwn -20.1%
|
2026-01-12 | $1,411,131Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2026-01-12 | $52,081 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-06
$164,400
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-01-06 | $164,400 | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Equity Compensation
2025-12-15
$0
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2025-12-15
$294,450
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2025-12-15 | $294,450 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2025-12-15
$164,319
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2025-12-15 | $164,319 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Other
2025-12-15
$158,998
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Other
|
2025-12-15 | $158,998 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
10b5-1 SellΔOwn -26.5%
2025-12-15
$1,773,267Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
10b5-1 SellΔOwn -26.5%
|
2025-12-15 | $1,773,267Large | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Equity Compensation
2025-12-15
$0
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Equity Compensation
2025-12-15
$0
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
HERSHBERG ROBERT
• Director
Discretionary SellΔOwn -33.0%
2025-12-10
$367,488
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Director
Discretionary SellΔOwn -33.0%
|
2025-12-10 | $367,488 | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Equity Compensation
2025-12-04
$0
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Equity Compensation
|
2025-12-04 | $0 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-12-04
$16,586
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-12-04 | $16,586 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-12-04
$35,168
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-12-04 | $35,168 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-12-04
$52,081
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-12-04 | $52,081 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-04
$166,100
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-04 | $166,100 | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Equity Compensation
2025-12-04
$0
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Equity Compensation
|
2025-12-04 | $0 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 Sell
2025-12-04
$212,377
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 Sell
|
2025-12-04 | $212,377 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-03
$506,415
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-03 | $506,415 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-12-01 | $2,367,462Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Equity Compensation
|
2025-11-28 | $0 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2025-11-28 | $78,469 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2025-11-28 | $29,250 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2025-11-28 | $1,145,822Large | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
PISKEL KYLE
• CFO
10b5-1 SellΔOwn -42.9%
2025-11-28
$3,174,990Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 SellΔOwn -42.9%
|
2025-11-28 | $3,174,990Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Equity Compensation
|
2025-11-28 | $0 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Equity Compensation
|
2025-11-28 | $0 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-26 | $703,284 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -51.0%
2025-11-21
$5,216,346Whale
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -51.0%
|
2025-11-21 | $5,216,346Whale | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$324,094
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $324,094 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$136,463
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $136,463 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$5,229
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $5,229 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$331,749
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $331,749 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$1,454,481Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $1,454,481Large | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$249,906
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $249,906 | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-20
$1,125,451Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-20 | $1,125,451Large | M | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-20
$837,187
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-20 | $837,187 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -50.1%
2025-11-20
$4,927,680Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -50.1%
|
2025-11-20 | $4,927,680Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Sell to Cover
|
2025-11-17 | $3,344 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-12 | $28,005 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-11 | $18,023 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-10 | $1,269,152Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-10
$148,200
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-11-10 | $148,200 | S | Form 4 |